{
    "Trade/Device Name(s)": [
        "FORA G71a Blood Glucose Monitoring System",
        "TD-4274 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K093712",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090187"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "February 19, 2010",
    "Summary Letter Received Date": "January 20, 2010",
    "Submission Date": "November 30, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FORA G71a Blood Glucose Meter",
        "TD-4274 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for FORA G71a and TD-4274 blood glucose monitoring systems using electrochemical biosensor technology",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from finger and alternative sites (palm, forearm, upper arm, calf, thigh) for use at home or by healthcare professionals to aid in monitoring diabetes control; not for diagnosis or screening of diabetes, nor for neonates.",
    "fda_folder": "Clinical Chemistry"
}